A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2004
12/14/2004	US6831166 Derivatized oligonucleotides having improved uptake and other properties
12/14/2004	US6831162 Protein/polypeptide-k obtained from Momordica charantia and a process for the extraction thereof
12/14/2004	US6831159 Method for purifying factor VIII/vWF company by cation-exchange chromatography
12/14/2004	US6831158 Granulocyte colony stimulating factor (g-csf) activity; polypeptide with an introduced and removed lysine residue conjugated to polyethylene glycol moieties; treatment of neutropenia or leukopenia
12/14/2004	US6831157 Process for the purification of serum albumin
12/14/2004	US6831155 Polypeptide for use in the diagnosis and treatment of cancer
12/14/2004	US6831153 Nucleotide sequences for use in the diagnosis and treatment of psychological disorders
12/14/2004	US6831150 Combining an aldehyde or ketone, base, the glycopeptide, acidifying the reaction mixture and combining with a reducing agent to alkylate the glycopeptide at the saccharide amine; glycopeptide antibiotics
12/14/2004	US6831099 Enzyme inhibition
12/14/2004	US6831086 In presence of proteins which retain biological activity; synergistic with benzalkonium chloride; easily removed by adsorption on active carbon or dialysis
12/14/2004	US6831070 Delivery of therapeutic gene products by intestinal cell expression
12/14/2004	US6831066 Amyloid precursor proteins with improved bioavailability; for treament of Alzheimer's disease
12/14/2004	US6831065 Anti-inflammatory compounds and uses thereof
12/14/2004	US6831064 Enhancing clearance of fluid and urinary waste into abdominal cavity; prolonging dialysis free intervals
12/14/2004	US6831063 Bridging Integrator-2(Bin2) nucleic acid molecules and proteins and uses therefor
12/14/2004	US6831061 Apicidin-derivatives, their synthetic methods and anti-tumor compositions containing them
12/14/2004	US6831060 Nucleotide sequences coding erythropoietin protein for use in the treatment of blood disorders
12/14/2004	US6831059 Compositions and methods for treating gonadotrophin related illnesses
12/14/2004	US6831058 Crosslinked gelatin gel preparation containing basic fibroblast growth factor
12/14/2004	US6831057 Use of NF-κB inhibition in combination therapy for cancer
12/14/2004	US6830937 Antibodies inhibit B-cells from binding CD28; animal immunization/vaccines; screening; fusion
12/14/2004	US6830923 Genetics units for inhibiting the function of RNA
12/14/2004	US6830916 Genetic engineering; enzyme that catalyzing phosphorylation
12/14/2004	US6830914 RGS-containing molecules and uses thereof
12/14/2004	US6830912 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
12/14/2004	US6830909 Identification and functional characterization of a novel ribosomal S6 protein kinase
12/14/2004	US6830906 The gene encoding for human manganese superoxide dismutase was isolated and inserted into a vector in conjunction with a synthetic linker wthich provides for enhanced efficiency in translation
12/14/2004	US6830900 Isolated human glutamate receptor DNA
12/14/2004	US6830894 Compounds and methods for modulating claudin-mediated functions
12/14/2004	US6830893 T20/DP178 is an activator of human phagocyte formyl peptide receptors
12/14/2004	US6830752 Comprises monoclonal sheep-derived antibodies and engineered antibody constructs, such as humanized single-chain Fv fragments and chimeric antibodies
12/14/2004	US6830751 Use of IL-12 antagonists in the treatment of rheumatoid arthritis
12/14/2004	US6830749 Antitumor agents; gene therapy
12/14/2004	US6830745 Compositions for treating biofilm
12/14/2004	US6830744 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
12/14/2004	CA2296535C Antisense oligonucleotide inhibition of ras
12/14/2004	CA2284278C Histone containing composition to treat rheumatoid arthritis
12/14/2004	CA2235038C Use of a tnf alpha antagonist for treating neurogenic skin redness
12/14/2004	CA2169355C Tumor suppressor protein prb2, related gene products, and dna encoding therefor
12/14/2004	CA2166109C Compositions for inhalation
12/14/2004	CA2146320C Antisense oligonucleotide inhibition of the ras gene
12/14/2004	CA2104957C Redirection of cellular immunity by receptor chimeras
12/14/2004	CA1341468C Preparation of functional human factor viii
12/13/2004	CA2467768A1 Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like loxl for stimulating the formation of elastic fibres
12/11/2004	CA2431560A1 Derivatives of streptogramins, their preparation and compositions containing them
12/09/2004	WO2004107618A2 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
12/09/2004	WO2004106532A1 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b
12/09/2004	WO2004106523A1 Compositions and methods for preventing and treating liver cirrhosis
12/09/2004	WO2004106522A1 Gene encoding a ribosome-inactivating protein, known as recombinant musarmin 4, expression in bacterial system, method of obtaining same and applications thereof
12/09/2004	WO2004106519A2 Mrp8/mrp14 inhibitors and the use thereof for preventing and/or treating hypertrophic scars and keloids
12/09/2004	WO2004106518A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in the treatment of cancer
12/09/2004	WO2004106509A1 Ceramide kinase-like proteins
12/09/2004	WO2004106505A1 A gutless adenovirus vector and the construction method thereof
12/09/2004	WO2004106504A1 The recombinant adeno-associated viruses carrying the human gamma interferon and the metrod for preparing them
12/09/2004	WO2004106498A1 Lactobacillus casei bd-ii strain and used to reduce blood cholesterol
12/09/2004	WO2004106411A2 Biodegradable poly(beta-amino esters) and uses thereof
12/09/2004	WO2004106373A1 Erythropoietin conjugate compounds with extended half-lives
12/09/2004	WO2004106371A1 Livin-derived peptides, compositions and uses thereof
12/09/2004	WO2004106370A1 M11l derived peptides and therapeutic use thereof
12/09/2004	WO2004106369A2 Complement inhibitors from ticks
12/09/2004	WO2004106366A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines
12/09/2004	WO2004106364A1 Stabilizing peptides and their use in the preparation of stabilized hiv inhibitors
12/09/2004	WO2004106359A2 Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals
12/09/2004	WO2004106300A1 Captopril derivatives
12/09/2004	WO2004105793A2 Soluble clca-1 and antagonists to clca-1
12/09/2004	WO2004105791A2 Recombinant anti-lhrh vaccines
12/09/2004	WO2004105790A1 Stabilized pharmaceutical peptide compositions
12/09/2004	WO2004105789A1 Grf analog compositions and their use
12/09/2004	WO2004105788A1 UNITARY COMBINATION OF FSH AND hCG
12/09/2004	WO2004105787A1 Methods of using combinations of egf-2 and egf-20 to treat central nervous system disorders
12/09/2004	WO2004105786A1 Adiponectin for treating cardiac disease
12/09/2004	WO2004105785A2 Use of pam
12/09/2004	WO2004105783A1 P-selectin targeting ligand and compositions thereof
12/09/2004	WO2004105782A2 Drug delivery systems for tumor targeting ngr-molecules and uses thereof
12/09/2004	WO2004105781A2 Stabilized pharmaceutical peptide compositions
12/09/2004	WO2004105780A2 Compositions comprising gastrin compounds and their use in diabetes
12/09/2004	WO2004105737A2 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004	WO2004105716A1 Lipidic protein-transfer systems and cosmetic/dermatological use thereof
12/09/2004	WO2004105699A2 Compositions of a cyclooxygenase-2 selective inhibitor and a cannabinoid agent for the treatment of central nervous system damage
12/09/2004	WO2004105504A2 Dietary supplements and methods of preparing and administering dietary supplements
12/09/2004	WO2004098626A3 The use of a polypeptide domain of slpi to modulate the tumorigenic and metastatic potential of cancer cells
12/09/2004	WO2004089422A3 Methods of treating and monitoring systemic lupus erythematosus in individuals
12/09/2004	WO2004087119A3 Compositions containing superoxide dismutase and a selected et 5-lipoxygenase inhibitor and uses thereof
12/09/2004	WO2004085712A3 Multi-functional polymeric materials and their uses
12/09/2004	WO2004085659A3 Mutant vesicular stomatitis viruses and uses thereof
12/09/2004	WO2004080429A3 Use of thiol-based compositions in ameliorating mucosal injury
12/09/2004	WO2004080408A3 Method of treating cancer with azaspirane compositions
12/09/2004	WO2004076479A3 Soluble ctla4 polypeptides and methods for making the same
12/09/2004	WO2004071413A3 Method and composition for potentiating an opiate analgesic
12/09/2004	WO2004069194A9 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes
12/09/2004	WO2004062618A3 Method for in vivo regulation of cardiac muscle contractility
12/09/2004	WO2004062586A3 Antineoplastic ether lipid compounds
12/09/2004	WO2004060310A3 Human growth hormone crystals and methods for preparing them
12/09/2004	WO2004060262A3 Modulators of notch signalling for use in immunotherpapy
12/09/2004	WO2004050828A3 Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer
12/09/2004	WO2004050692A3 Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production
12/09/2004	WO2004049901A3 Methods of treating cerebral ischemia
12/09/2004	WO2004047759A3 Composition for treating chlamydia infections and method for identifying same
12/09/2004	WO2004038003A3 Human polypeptides encoded by polynucleotides and methods of their use
12/09/2004	WO2004037851A3 Colostrinin and peptides thereof as modulators of intracellular signaling molecules and inhibitors of apoptosis

1 ... 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 ... 3163